2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 6.716 | 82.111 | 503.145 | 206.663 | 274.764 | 712.546 | 2.213.155 | 2.135.159 | 1.396.411 | 3.570.218 |
Total Income - EUR | 6.716 | 82.111 | 503.148 | 206.668 | 291.855 | 719.658 | 2.384.160 | 2.135.255 | 1.517.239 | 3.527.192 |
Total Expenses - EUR | 106 | 59.547 | 393.727 | 185.236 | 280.543 | 454.411 | 1.488.963 | 1.887.133 | 1.504.388 | 3.298.478 |
Gross Profit/Loss - EUR | 6.609 | 22.564 | 109.421 | 21.433 | 11.312 | 265.247 | 895.197 | 248.122 | 12.851 | 228.714 |
Net Profit/Loss - EUR | 6.408 | 18.954 | 91.908 | 19.379 | 8.393 | 258.051 | 775.824 | 211.107 | 4.473 | 187.971 |
Employees | 0 | 1 | 8 | 10 | 17 | 25 | 48 | 51 | 39 | 42 |
Check the financial reports for the company - Romalexin Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 2.165 | 10.282 | 45.976 | 85.822 | 84.505 | 189.170 | 275.736 | 302.200 | 345.449 | 341.501 |
Current Assets | 31.776 | 79.597 | 251.951 | 110.987 | 206.625 | 192.775 | 1.003.242 | 1.019.540 | 620.996 | 2.390.286 |
Inventories | 9.849 | 28.765 | 29.686 | 33.836 | 56.147 | 37.120 | 37.183 | 59.089 | 237.153 | 57.012 |
Receivables | 12.921 | 14.784 | 33.035 | 29.838 | 95.689 | 63.688 | 762.483 | 362.565 | 219.770 | 1.908.234 |
Cash | 9.006 | 36.049 | 189.230 | 47.313 | 54.789 | 91.967 | 203.577 | 597.886 | 164.072 | 425.040 |
Shareholders Funds | 33.941 | 53.178 | 144.544 | 152.720 | 124.380 | 280.203 | 974.549 | 844.859 | 713.211 | 789.148 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 0 | 37.158 | 153.835 | 44.533 | 198.809 | 112.001 | 316.641 | 321.168 | 181.922 | 1.871.321 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4100 - 4100" | |||||||||
CAEN Financial Year |
4120
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Romalexin Srl